PS25/12 tightens safeguarding by mandating daily, evidence-backed reconciliations to prove customer funds are protected by May 2026.
Cosegic strengthens financial crime, regulatory risk and compliance capabilities through its acquisition of FINTRAIL, expanding specialist support for global firms.
By 2026, FCA supervision for UK payments firms will be less about policy and more about proof. The focus is on governance, control effectiveness and evidenced outcomes, with limited tolerance for growth that outpaces risk management and operational resilience.
The UK government plans to introduce a Provisional Licence Regime to help start-ups gain FCA authorisation with time-limited permissions and reduced barriers to entry.
Stay updated with January 2026's top regulatory changes for investment firms, from enhancing fund liquidity risk management, Consumer Duty and boosting the UK Investment culture.
Explore FCA regulatory developments for insurance, mortgages and consumer credit firms.
Explore FCA regulatory priorities for investment firms, including growth, digital innovation, private markets, outcomes-focused regulation and financial crime.
UK crypto regulation is moving crypto firmly into the financial mainstream, forcing firms to shift from growth-led models to capital-aware, well-governed and risk-controlled operations.
The 2025 Life Insurance Stress Test (LIST 2025) provides the first clear view of how UK life insurers are performing under the Solvency UK regime, confirming the sector’s resilience even under severe but plausible stress scenarios and reinforcing the importance of strong risk management and capital planning.
FCA Consumer Duty remains a top priority under the FCA Strategy 2025–2030. Learn what firms can expect from reviews, fair value assessments and sector-specific work.
Stablecoin regulation is reshaping global payments. Explore how UK, US and EU regulatory approaches are influencing strategy, competition and the future of digital finance.
FCA reviews MIFIDPRU regulatory reporting and highlights key issues with ICARA, K-factors, SNI status and OFTR calculations.